Details of the Drug Reposition

General Information of This Drug (ID: DMJKWMA)

Drug Name
Tanezumab   DMJKWMA
Drug Type
Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Neuropathic pain DISC905E 8E43.0 Phase 3 [1]
Osteoarthritis DIS05URM FA00-FA05 Phase 3 [1]
Chronic low back pain DISFIFVC MG30.02 Phase 3 [1]
Pain DIS4RWOW MG30-MG3Z Phase 3 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)